A patient with chronic kidney disease (CKD) stage 4 presents with elevated serum creatinine, decreased eGFR, and signs of hyperkalemia. The patient also has a history of hypertension and diabetes with suboptimal glycemic control. Which nursing intervention is most appropriate to address the patient's current condition and prevent further complications?

B) Initiate dietary counseling to reduce potassium intake and provide education on glycemic control.

A) Administer a potassium-sparing diuretic to manage fluid overload and hypertension.

B) Initiate dietary counseling to reduce potassium intake and provide education on glycemic control.

C) Increase the dose of ACE inhibitors to control hypertension and protect renal function.

D) Encourage increased fluid intake to improve renal perfusion and flush out excess potassium.

A patient with stage 4 chronic kidney disease (CKD) and type 2 diabetes presents with worsening renal function, as indicated by an increase in serum creatinine and a decrease in eGFR. She also shows signs of hyperkalemia and poor glycemic control. Which nursing intervention is most appropriate to address her current condition and prevent further renal deterioration?

B) Educate the patient on the importance of strict glycemic control and collaborate with the dietitian for a renal-friendly and diabetic-appropriate diet plan.

A) Increase dietary potassium intake to balance electrolyte levels.

B) Educate the patient on the importance of strict glycemic control and collaborate with the dietitian for a renal-friendly and diabetic-appropriate diet plan.

C) Encourage the patient to increase fluid intake to improve kidney filtration.

D) Recommend the use of over-the-counter NSAIDs for her occasional headaches.

A patient with diabetes, hypertension, and advanced chronic kidney disease is exhibiting signs of fluid overload, including bilateral lower extremity edema and crackles on lung auscultation. The medical team has initiated loop diuretics and adjusted her antihypertensive therapy. What is the nurse's priority intervention to monitor for potential complications associated with these changes?

C) Evaluate lung sounds frequently to detect worsening pulmonary edema

A) Monitor blood glucose levels closely to prevent hypoglycemia

B) Assess for signs of hypokalemia by monitoring serum potassium levels

C) Evaluate lung sounds frequently to detect worsening pulmonary edema

D) Check blood pressure regularly to ensure it remains within target range

A patient with diabetes, hypertension, and advanced chronic kidney disease has recently been transitioned from oral hypoglycemic agents to insulin therapy and started on an ACE inhibitor. She presents with signs of fluid overload, including bilateral lower extremity edema and crackles on lung auscultation. Her serum creatinine is 2.7 mg/dL, and potassium level is 5.5 mmol/L. What is the priority nursing intervention in this situation?

A) Administer a loop diuretic as prescribed and monitor fluid status closely.

B) Increase the insulin dose to improve glycemic control and reduce renal strain.

C) Restrict the patient's fluid intake to reduce the risk of fluid overload.

D) Educate the patient on reducing potassium intake to manage hyperkalemia.

A patient with a history of renal insufficiency and hypertension is being treated with loop diuretics for fluid overload. The patient develops orthostatic hypotension. Which nursing intervention is most appropriate to address this new complication while continuing to manage the patient's fluid status?

C) Educate the patient on slowly changing positions from lying to standing

A) Increase the frequency of standing blood pressure measurements

B) Administer an additional dose of furosemide to further reduce fluid overload

C) Educate the patient on slowly changing positions from lying to standing

D) Discontinue the furosemide and increase the dose of antihypertensive medications

A patient receiving loop diuretics for fluid overload presents with orthostatic hypotension. Which nursing intervention should be prioritized to address this new complication while continuing to manage her fluid status?

B) Educate the patient on slow position changes to prevent dizziness.

A) Increase the dosage of loop diuretics to enhance fluid removal.

B) Educate the patient on slow position changes to prevent dizziness.

C) Restrict fluid intake further to prevent fluid overload.

D) Discontinue all antihypertensive medications immediately.

A patient with orthostatic hypotension is experiencing dizziness and has been prescribed a combination of a beta-blocker and an ACE inhibitor. Which nursing intervention is most appropriate to reduce the patient's risk of falls?

C) Instruct the patient to rise slowly from a lying or seated position

A) Encourage the patient to stand quickly to minimize dizziness duration

B) Advise the patient to avoid drinking fluids in the evening to prevent nocturia

C) Instruct the patient to rise slowly from a lying or seated position

D) Suggest the patient take all medications in the morning to avoid evening hypotension

A patient with a history of hypertension experiences orthostatic hypotension after starting a new medication regimen that includes a beta-blocker, an ACE inhibitor, and a diuretic. After adjusting her medication, she shows improvement in her symptoms. However, her renal function remains compromised, with elevated creatinine and potassium levels. Which nursing intervention is most appropriate to address these lab abnormalities while managing her orthostatic hypotension?

B) Educate the patient on dietary potassium restriction.

A) Increase fluid intake to dilute serum potassium levels.

B) Educate the patient on dietary potassium restriction.

C) Administer a potassium-sparing diuretic to balance potassium levels.

D) Discontinue all antihypertensive medications to allow renal recovery.

A patient with diabetes and chronic kidney disease is showing signs of increased blood urea nitrogen (BUN) levels and mild proteinuria. What is the most appropriate nursing intervention to prevent further renal impairment in this patient?

B) Monitor urine output and signs of fluid overload closely.

A) Encourage increased fluid intake to dilute the urine.

B) Monitor urine output and signs of fluid overload closely.

C) Advise the patient to increase their protein intake.

D) Suggest the use of over-the-counter diuretics for edema.

A patient with a history of hypertension and diabetes is experiencing increased blood urea nitrogen (BUN) levels and mild proteinuria. The healthcare team has adjusted the patient's medication regimen and diet to manage these issues. As a nurse, which intervention should be prioritized to protect the patient's renal function while maintaining adequate blood pressure control?

B) Monitor the patient's blood pressure and adjust the diuretic dose as prescribed.

A) Encourage the patient to drink more fluids to flush out the kidneys.

B) Monitor the patient's blood pressure and adjust the diuretic dose as prescribed.

C) Administer a high-protein diet to support kidney function.

D) Instruct the patient to increase potassium intake to offset diuretic effects.

older patient with diabetes and chronic kidney issues - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic hyperglycemia in diabetes leads to advanced glycation end-products (AGEs) formation, damaging kidney glomeruli and impairing filtration.

• Secondary mechanism: Hypertension, common in older diabetic patients, exacerbates glomerular damage by increasing intraglomerular pressure, further reducing kidney function.

• Key complication: Progressive nephron loss results in chronic kidney disease (CKD), leading to toxin accumulation and electrolyte imbalances, complicating diabetes management and increasing cardiovascular risk.

Patient Profile

Demographics:

78-year-old female, retired school teacher

History:

• Key past medical history: Type 2 diabetes mellitus diagnosed 15 years ago, chronic kidney disease stage 3 for the past 5 years, hypertension, hyperlipidemia

• Current medications: Metformin 500 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 20 mg once daily, Furosemide 40 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in the lower extremities

• Key symptoms: Shortness of breath on exertion, reduced urine output, occasional dizziness, and persistent dry skin

• Vital signs: Blood pressure 160/90 mmHg, heart rate 92 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, several diagnostic tests were ordered to further investigate the patient's condition. The comprehensive metabolic panel revealed a serum creatinine level of 2.5 mg/dL, an increase from her baseline of 1.8 mg/dL, indicating worsening kidney function. The estimated glomerular filtration rate (eGFR) had decreased to 28 mL/min/1.73m², confirming progression from stage 3 to stage 4 chronic kidney disease. Her blood urea nitrogen (BUN) was elevated at 45 mg/dL, and potassium levels were slightly raised at 5.3 mmol/L, suggesting the onset of hyperkalemia, a common electrolyte imbalance in advanced CKD.

In addition to these findings, the patient's HbA1c was recorded at 8.1%, showing suboptimal glycemic control, which could further exacerbate nephropathy and other diabetes-related complications. A urinalysis indicated moderate proteinuria, highlighting increased renal impairment and increased cardiovascular risk. An echocardiogram was also performed due to her exertional dyspnea, revealing mild left ventricular hypertrophy and reduced diastolic function, likely a consequence of long-standing hypertension and possibly contributing to her symptoms of shortness of breath and fatigue.

These results point to a significant deterioration in renal function and suggest the need for a reevaluation of her current management plan. Adjustments to her medication regimen, such as careful consideration of her antihypertensives and potential initiation of insulin therapy, will be necessary. Furthermore, these findings warrant close monitoring of her fluid status and electrolyte levels to prevent further complications. This will require a coordinated approach to ensure her diabetes and hypertension are optimally managed, while also addressing her advancing CKD.

Section 2

New Complications

As the medical team reviewed the patient's recent diagnostic results, they decided to adjust her treatment plan to manage her worsening kidney function and suboptimal glycemic control. The patient was transitioned from oral hypoglycemic agents to insulin therapy to achieve better glucose regulation, given her elevated HbA1c of 8.1%. This change aimed to mitigate further renal damage by maintaining tighter blood glucose control. Additionally, her antihypertensive regimen was altered to include an angiotensin-converting enzyme (ACE) inhibitor, which not only helps control blood pressure but also offers renal protective effects by reducing proteinuria.

Despite these proactive measures, the patient began to exhibit signs of fluid overload over the following days. On assessment, she presented with increasing bilateral lower extremity edema, mild jugular venous distension, and crackles on auscultation of the lungs. Her blood pressure remained elevated at 160/95 mmHg, and she reported increased fatigue and dyspnea on exertion. Laboratory tests showed a further rise in serum creatinine to 2.7 mg/dL and persistent hyperkalemia with a potassium level of 5.5 mmol/L. These findings suggested that her renal function continued to decline, and the fluid overload was complicating her cardiovascular status.

This new development necessitated immediate intervention to address her fluid balance and prevent acute decompensation. The team considered the cautious use of loop diuretics to manage her volume status, while closely monitoring her electrolytes to avoid exacerbating her hyperkalemia. This situation underscored the complexity of managing a patient with coexisting diabetes, hypertension, and advanced chronic kidney disease, highlighting the need for a multidisciplinary approach and continuous reassessment of her therapeutic strategies. The goal was to stabilize her condition and prevent further complications while planning for potential future interventions, including possible dialysis.

Section 3

The medical team decided to closely monitor the patient's response to the loop diuretics, particularly given her precarious renal status and electrolyte imbalance. Over the next 48 hours, careful titration of furosemide was initiated, with the aim of relieving her fluid overload while minimizing the risk of worsening her hyperkalemia. The patient was placed on a low-potassium diet to further mitigate the risk of potassium accumulation. Her daily fluid intake was restricted, and she was encouraged to adhere strictly to her dietary and medication regimen.

The initial response to the diuretic therapy was promising. The patient experienced a reduction in bilateral lower extremity edema, and her lung auscultation revealed a decrease in crackles, suggesting improved pulmonary status. Her blood pressure showed a slight improvement, dropping to 150/90 mmHg, although it remained higher than the target range. Despite these positive signs, her laboratory tests indicated persistent challenges. The serum creatinine level remained elevated at 2.8 mg/dL, showing no significant improvement, and the potassium level hovered at 5.4 mmol/L, necessitating ongoing vigilance.

Despite these clinical interventions, the patient developed a new complication: she began to experience episodes of orthostatic hypotension, characterized by dizziness and mild syncope when transitioning from lying to standing positions. This raised concerns about the balance between adequate fluid removal and over-diuresis, compounded by her existing antihypertensive regimen. The team recognized the need to reassess her blood pressure management strategy, possibly adjusting her medications to avoid further hypotensive episodes while continuing to address her fluid overload and renal insufficiency. This intricate scenario required a reevaluation of her therapeutic plan, emphasizing the importance of a tailored approach that considered the interconnectedness of her multiple conditions.

Section 4

The medical team decided to focus on the new complication of orthostatic hypotension. They conducted a thorough initial assessment to better understand the underlying causes and to devise an appropriate strategy. Upon examination, the patient's blood pressure readings were 150/90 mmHg when supine, but dropped significantly to 110/70 mmHg when standing. Her heart rate increased from 82 beats per minute to 110 beats per minute in response to the position change, indicating a compensatory tachycardia. The team noted that while her blood pressure was somewhat controlled when lying down, the abrupt changes upon standing suggested a need for a nuanced adjustment of her antihypertensive regimen.

Additionally, a review of her current medications revealed that the patient was on a combination of a beta-blocker and an ACE inhibitor, both of which could contribute to her hypotensive episodes, especially in the context of diuretic use. The decision was made to reduce the dose of her beta-blocker temporarily and to monitor her response closely. This required careful coordination with her diuretic therapy to ensure that fluid overload did not recur. The team also recommended non-pharmacologic strategies such as encouraging the patient to rise slowly from a seated or lying position and to wear compression stockings to mitigate the symptoms of orthostatic hypotension.

Subsequent monitoring over the next 24 hours revealed a slight improvement in her orthostatic blood pressure readings, with supine measurements at 148/88 mmHg and standing at 118/78 mmHg. Her dizziness decreased, and she experienced no further episodes of syncope, suggesting that the modifications to her medication regimen were having the desired effect. However, her renal function and potassium levels still posed challenges, with serum creatinine remaining at 2.9 mg/dL and potassium at 5.5 mmol/L. This highlighted the need for ongoing monitoring and the potential reconsideration of her diuretic dosage to achieve a delicate balance between fluid management and renal protection. The team recognized that the patient's journey was far from over, and that continuous reassessment and adaptation of her treatment plan were essential to optimize her outcomes.

Section 5

As the medical team continued to monitor the patient, a new set of diagnostic results provided further insight into her condition. A comprehensive metabolic panel revealed a slight increase in her blood urea nitrogen (BUN) levels, now at 45 mg/dL, which indicated a potential exacerbation of her kidney issues. Additionally, a urinalysis showed mild proteinuria, a sign that her kidneys were under stress. These findings prompted the team to reassess her current medication regimen and explore the possibility of further reducing her diuretic dose to protect her renal function while maintaining adequate blood pressure control.

In response to these developments, the team decided to implement a more aggressive fluid management strategy. They introduced a low-sodium diet to help mitigate fluid retention and reduce the strain on her kidneys. Furthermore, they scheduled a renal ultrasound to evaluate the structural integrity of her kidneys and ruled out any acute conditions such as hydronephrosis or renal artery stenosis. This imaging would provide crucial information to guide their ongoing management plan and ensure that no underlying issues were being overlooked.

Despite these challenges, the patient's overall status showed signs of stabilization. Her orthostatic hypotension continued to improve, and she reported feeling less fatigued and more alert, which suggested that the adjustments to her medication and lifestyle were effective. However, the team remained vigilant, understanding that her complex medical history required continuous monitoring and adaptation of her treatment plan. The next steps involved close follow-up appointments to reassess her renal function and adjust her medications as needed, with the aim of achieving a delicate balance between managing her diabetes, blood pressure, and kidney health.